CHEPLAPHARM Arzneimittel GmbH

Publications

This section provides relevant information as well as ongoing and timely updates on the strategic and operative success stories of our steadily growing Company.

support_agent

Your contact persons

Jens Remmers

Head of Treasury & Investor Relations

IR center of information

Financial Reports

1st December 2022
Earnings Call Q3 2022 Results
29th November 2022
Publication Quarterly Report Q3 2022
1st September 2022
Earnings Call H1 2022 Results
29th August 2022
Publication 1st Half-Year Report 2022
2nd June 2022
Investor Call Quarterly Report Q1 2022
31st May 2022
Publication Quarterly Report Q1 2022
10th May 2022
Investor Call Full Financial Year 2021 audited
29th April 2022
Publication Full Financial Year 2021 audited
30th November 2021
Investor Call Quarterly Report Q3 2021
19th November 2021
Publication Quarterly Report Q3 2021
24th August 2021
Investor Call Quarterly Report Q2 2021
20th August 2021
Publication Quarterly Report Q2 2021
Find out how you can benefit

Publications

The latest from CHEPLAPHARM

View:
format_list_bulleted grid_view

08/29/2022

CHEPLAPHARM increases revenue and earnings in the first half of 2022
Press releases
Read more chevron_right

06/01/2022

CHEPLAPHARM strengthens its oncology portfolio
Press releases
Read more chevron_right

05/16/2022

CHEPLAPHARM acquires rights to CMV medicine
Press releases
Read more chevron_right

04/29/2022

CHEPLAPHARM continues profitable growth track in 2021 as well
Press releases
Read more chevron_right

03/21/2022

Significant and sustainable site expansion
Press releases
Read more chevron_right

03/01/2022

CHEPLAPHARM acquires additional oncology drugs
Press releases
Read more chevron_right

02/23/2022

Jens Rothstein hands over his CFO role to Kia Parssanedjad
Press releases
Read more chevron_right

02/11/2022

CHEPLAPHARM announces successful pricing of Term Loan B
Investor Relations
Read more chevron_right

11/19/2021

CHEPLAPHARM continues strong Growth
Archive Press releases
Read more chevron_right

10/13/2021

CHEPLAPHARM signed deal
Press releases
Read more chevron_right

Investor Relations topics

Back to top expand_less